• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 433068 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414156887 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414156887 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Stock Investors Sell Off Shares of Halozyme Therapeutics, Down 12.4%

Published on Thu, 01/31/2013 - 11:13
By Peter Chu

Halozyme Therapeutics (NASDAQ:HALO) is one of today's biggest movers, down 12.4% to $6.21. The S&P is trading fractionally lower to 1,501 and the Dow is trading fractionally higher to 13,918.

Halozyme Therapeutics has overhead space with shares priced $6.21, or 37.4% below the average consensus analyst price target of $9.92. The stock should find initial resistance at its 50-day moving average (MA) of $6.61 and further resistance at its 200-day MA of $7.09.

Over the past year, Halozyme Therapeutics has traded in a range of $3.86 to $13.50 and is now at $6.21, 61% above that low. The 200-day and 50-day moving averages have moved 0.67% lower and 2.40% higher over the past week, respectively.

Halozyme Therapeutics, Inc. develops and commercializes recombinant human enzymes for the infertility, ophthalmology, and oncology communities. The Company's product portfolio is based on intellectual property covering the family of human enzymes known as hyaluronidases. Halozyme's products offer an alternative to slaughterhouse-derived extracts that carry contamination risks.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

International Flavors & Fragrances has R...

Here are 5 stocks in the Specialty Chemicals industry ranked by performance. We compil ...

Entertainment Properties Trust had the L...

Analysis was conducted on the Specialized REITs industry to measure relative performanc ...

Shares of YRC Worldwide Rank the Highest...

Here are the top 5 stocks in the Trucking industry ranked by performance. We compiled ...

Shares of Interactive Brokers Underperfo...

Here are 5 stocks in the Specialized Finance industry ranked by performance. We compil ...

Carpenter Technology is Among the Compan...

We looked at the Steel industry and measured relative performance to find the top stock ...

Short-term Underperformance Detected in ...

Analysis was conducted on the Semiconductors industry to measure relative performance t ...

Top 5 Companies in the Specialty Stores ...

Here are the top 5 stocks in the Specialty Stores industry ranked by performance. We c ...

National Retail Properties had the Lowes...

Here are 5 stocks in the Retail REITs industry ranked by performance. We compiled the ...